Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,706 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

NCT06837233

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Beijing Shijitan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Cangzhou Central Hospital Cangzhou, Hebei, China
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

NCT06315426

Conditions
Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations
  • Hebei Petro China Central Hospital Langfang, Hebei, China
  • Central Hospital of Qinghe County Xingtai, Hebei, China
  • Zhengzhou Central Hospital Zhengzhou, Henan, China
  • Jingzhou Central Hospital Jingzhou, Hubei, China
View all 15 locations
View Trial Details
Active, Not Recruiting

Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction

NCT05135377

Conditions
Anaphylaxis, Hypersensitivity, Hypersensitivity, Immediate, +1 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Stollery Children's Hospital Edmonton, Alberta, Canada
  • McMaster University Hamilton, Ontario, Canada
  • Children's Hospital of Western Ontario London, Ontario, Canada
View Trial Details
Active, Not Recruiting

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

NCT06920771

Conditions
Dust Mite Allergy, House Dust Mite Allergy, House Dust Mite Rhinitis, +12 more
Locations
  • UMBAL Kaspela Plovdiv, Bulgaria
  • Medical Center Prolet EOOD Rousse, Bulgaria
  • Medical Center Smolyan Smolyan, Bulgaria
  • DCC Convex Sofia, Bulgaria
View all 68 locations
View Trial Details

Related conditions